Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States (Q37103050)
Jump to navigation
Jump to search
scientific article published on 04 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States |
scientific article published on 04 March 2016 |
Statements
1 reference
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States (English)
1 reference
Giovanni Martinelli
1 reference
Michele Baccarani
1 reference
Dietger Niederwieser
1 reference
Jane F Apperley
1 reference
Charles A Schiffer
1 reference
Susanne Saussele
1 reference
Francois Guilhot
1 reference
Francois-Xavier Mahon
1 reference
Joelle Guilhot
1 reference
William V Padula
1 reference
Rudiger Hehlmann
1 reference
Ekkehard Eigendorff
1 reference
Rudiger Hehlmann
1 reference
Jiri Mayer
1 reference
Martin C Müller
1 reference
Richard T Silver
1 reference
Bengt Simonsson
1 reference
Rena M Conti
1 reference
1 reference
1 reference
Identifiers
1 reference